Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Pharmacokinetic Parameters Clinical Uses Type 2 diabetes mellitus Obesity management Cardiovascular risk reduction in patients with diabetes Nonalcoholic fatty liver disease (off-label, investigational) Adverse Effects Nausea and vomiting Diarrhea Pancreatitis (rare) Thyroid C-cell tumors (rodent studies) Injection site reactions (if injectable) Comparative Analysis MCQs GLP-1 receptor agonists primarily act on: a) Alpha cells b) Beta cells c) Delta cells d) Hepatocytes Answer: b) Beta cells These drugs increase insulin secretion in a: a) Continuous manner b) Glucose-independent way c) Glucose-dependent way d) Inhibited state Answer: c) Glucose-dependent way Which of the following is a known adverse effect of GLP-1 agonists
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy
And then I start comparing
The dopamine reduction caused by GLP-1s may make the medications effective for treating substance use and other behavioral disorders that are reward-pathway based
Re-ignite Your Passion
Youll receive a secure video link by email
US$ 29.00
US$ 27.03
US$ 21.78
US$ 27.03
